Brepocitinib Demonstrates Promising Phase 2 Results in Uveitis Treatment Jacinthlyn Sylvia12 April 2024 4:15 AM ISTPriovant Therapeutics recently unveiled promising results from the NEPTUNE Phase 2 study by testing the efficacy of brepocitinib in patients with...
Fluocinolone acetonide implants reliable option to treat non-infectious uveitis Niveditha Subramani27 Oct 2023 8:00 PM ISTFluocinolone acetonide (FAc) intravitreal implant 0.19 mg (ILUVIEN®) is a nonbiodegradable, injectable, corticosteroid implant that is approved in...
No Increase in Non-Infectious Uveitis Risk in COVID-19 Vaccinated People Jacinthlyn Sylvia17 Aug 2023 8:00 PM ISTIn a recent study published in Ophthalmology Journal indicated no increased risk of Non-Infectious Uveitis (NIU) following COVID-19 vaccination in...
Low dose fluocinolone acetonide implant safe in noninfectious uveitis Jacinthlyn Sylvia3 April 2023 8:00 PM ISTWith relatively low incidence of ocular hypertension necessitating intervention, the 0.18-mg fluocinolone acetonide implant (FAi) appears to be a...
Topical licaminlimab effective against non-infectious uveitis: Study Jacinthlyn Sylvia18 July 2022 8:00 PM ISTUSA: A new study published in Translational Vision Science & Technology provided insight on how Licaminlimab is the first biologic that has...
